Pediatric ED Visits for Mental, Behavioral Conditions Increased During School Term
THURSDAY, Sept. 21, 2023 (HealthDay News) — For children and adolescents, the number and proportion of weekly emergency department visits for mental health and behavioral conditions is higher during the academic year, according to research published…
Learn MoreFluticasone Furoate Does Not Cut Time to COVID-19 Symptom Resolution
THURSDAY, Sept. 21, 2023 (HealthDay News) — For outpatients with mild-to-moderate COVID-19, inhaled fluticasone furoate does not shorten time to symptom resolution, according to a study published in the Sept. 21 issue of the New England Journal of Me…
Learn MoreDabrafenib, Trametinib Active in Pediatric Glioma With BRAF V600
THURSDAY, Sept. 21, 2023 (HealthDay News) — Dabrafenib plus trametinib results in significantly more responses and longer progression-free survival than standard chemotherapy for pediatric patients with low-grade glioma with BRAF V600 mutations, acco…
Learn MoreAdverse Childhood Experiences Common in Schizophrenia
WEDNESDAY, Sept. 20, 2023 (HealthDay News) — Patients with schizophrenia often have adverse childhood experiences (ACEs), according to a study published online Aug. 28 in Frontiers in Psychiatry.Lei Zhang, Ph.D., from Tongji University in Shanghai, a…
Learn MoreCoronary Microvascular Dysfunction ID’d in 31.5 Percent With Psoriasis
WEDNESDAY, Sept. 20, 2023 (HealthDay News) — Coronary microvascular dysfunction (CMD) occurs in 31.5 percent of patients with psoriasis, with disease severity and duration associated with increased risk, according to a study published in the October …
Learn MoreStudy Looks at Treatment Patterns for Alopecia Areata
WEDNESDAY, Sept. 20, 2023 (HealthDay News) — For patients with alopecia areata (AA), corticosteroids are the most commonly used treatment, and by one year, 71.8 percent are receiving no treatment, according to a study published online Sept. 20 in JAM…
Learn MoreProteinuria Higher With Dasatinib Exposure in Chronic Myelogenous Leukemia
WEDNESDAY, Sept. 20, 2023 (HealthDay News) — For patients with chronic myelogenous leukemia (CML) receiving tyrosine-kinase inhibitor therapy, exposure to dasatinib is associated with increased odds of proteinuria, according to a study published onli…
Learn More5-ASA Discontinuation Common Within First Year of Ulcerative Colitis Diagnosis in Youth
WEDNESDAY, Sept. 20, 2023 (HealthDay News) — For adolescents and young adults diagnosed with ulcerative colitis (UC), the rate of discontinuation of 5-aminosalicylic acid (5-ASA) maintenance treatment is high within the first year, according to a stu…
Learn MorePractice Points Developed for Treatment of Outpatient COVID-19
WEDNESDAY, Sept. 20, 2023 (HealthDay News) — In an updated clinical guideline issued by the American College of Physicians and published online Sept. 19 in the Annals of Internal Medicine, living, rapid practice points are presented for the outpatien…
Learn MoreRisk for Esophageal Adenocarcinoma Not Increased With Nonerosive GERD
WEDNESDAY, Sept. 20, 2023 (HealthDay News) — Patients with nonerosive gastroesophageal reflux disease (GERD) do not have an increased risk for esophageal adenocarcinoma compared with the general population, according to a study published online Sept….
Learn More